Skip to content

Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy

Comparison of Palonosetron With Combined Palonosetron and Midazolam for Preventing Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03933605
Enrollment
88
Registered
2019-05-01
Start date
2017-07-10
Completion date
2019-02-08
Last updated
2019-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Nausea, Postoperative Vomiting

Keywords

postoperative nausea and vomiting, midazolam, palonosetron

Brief summary

In the present study, midazolam and palonosetron in combination were more effective than palonosetron alone in lowering the incidence and severity of postoperative nausea and vomiting in the initial 2 h after laparoscopic cholecystectomy. Postoperative clinical complications were not different in both groups.

Interventions

DRUGmidazolam and palonosetron group

intravenous midazolam and palonosetron administraion as prevention of postoperative nausea and vomiting

DRUGpalonosetron group

intravenous palonosetron administraion as prevention of postoperative nausea and vomiting

Sponsors

Yeungnam University College of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* The patients (aged 20 to 65 years) scheduled for laparoscopic cholecystectomy with American Society of Anesthesiologists (ASA) physical status classification of 1 or 2

Exclusion criteria

* The patients with a history of allergy to any other drugs used in this study, gastrointestinal disorder, previous PONV, pregnant woman, breastfeeding woman, use of antiemetics within 24 hours or body mass index \> 30 kg/m2

Design outcomes

Primary

MeasureTime frameDescription
incidence of postoperative nausea and vomiting24 hours after surgery0=none; 1=occur
severity of postoperative nausea and vomiting24 hours after surgery0 = absent; 1 = mild; 2 = moderate; 3 = severe

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026